132 related articles for article (PubMed ID: 1435880)
1. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease.
Spencer DD; Robbins RJ; Naftolin F; Marek KL; Vollmer T; Leranth C; Roth RH; Price LH; Gjedde A; Bunney BS
N Engl J Med; 1992 Nov; 327(22):1541-8. PubMed ID: 1435880
[TBL] [Abstract][Full Text] [Related]
2. Adrenal medullary transplantation into the brain for treatment of Parkinson's disease: clinical outcome and neurochemical studies.
Ahlskog JE; Kelly PJ; van Heerden JA; Stoddard SL; Tyce GM; Windebank AJ; Bailey PA; Bell GN; Blexrud MD; Carmichael SW
Mayo Clin Proc; 1990 Mar; 65(3):305-28. PubMed ID: 2314121
[TBL] [Abstract][Full Text] [Related]
3. CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson's disease.
LeWitt P; Schultz L; Auinger P; Lu M;
Brain Res; 2011 Aug; 1408():88-97. PubMed ID: 21784416
[TBL] [Abstract][Full Text] [Related]
4. Long-term clinical outcome of fetal cell transplantation for Parkinson disease: two case reports.
Kefalopoulou Z; Politis M; Piccini P; Mencacci N; Bhatia K; Jahanshahi M; Widner H; Rehncrona S; Brundin P; Björklund A; Lindvall O; Limousin P; Quinn N; Foltynie T
JAMA Neurol; 2014 Jan; 71(1):83-7. PubMed ID: 24217017
[TBL] [Abstract][Full Text] [Related]
5. Dopamine cell transplantation for Parkinson's disease: the importance of controlled clinical trials.
Freed CR; Zhou W; Breeze RE
Neurotherapeutics; 2011 Oct; 8(4):549-61. PubMed ID: 21997523
[TBL] [Abstract][Full Text] [Related]
6. Induced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brain.
Emborg ME; Liu Y; Xi J; Zhang X; Yin Y; Lu J; Joers V; Swanson C; Holden JE; Zhang SC
Cell Rep; 2013 Mar; 3(3):646-50. PubMed ID: 23499447
[TBL] [Abstract][Full Text] [Related]
7. Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease.
Barker RA; Barrett J; Mason SL; Björklund A
Lancet Neurol; 2013 Jan; 12(1):84-91. PubMed ID: 23237903
[TBL] [Abstract][Full Text] [Related]
8. Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes.
Ma Y; Tang C; Chaly T; Greene P; Breeze R; Fahn S; Freed C; Dhawan V; Eidelberg D
J Nucl Med; 2010 Jan; 51(1):7-15. PubMed ID: 20008998
[TBL] [Abstract][Full Text] [Related]
9. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease.
Freed CR; Breeze RE; Rosenberg NL; Schneck SA; Kriek E; Qi JX; Lone T; Zhang YB; Snyder JA; Wells TH
N Engl J Med; 1992 Nov; 327(22):1549-55. PubMed ID: 1435881
[TBL] [Abstract][Full Text] [Related]
10. Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Widner H; Tetrud J; Rehncrona S; Snow B; Brundin P; Gustavii B; Björklund A; Lindvall O; Langston JW
N Engl J Med; 1992 Nov; 327(22):1556-63. PubMed ID: 1435882
[TBL] [Abstract][Full Text] [Related]
11. Designing stem-cell-based dopamine cell replacement trials for Parkinson's disease.
Barker RA;
Nat Med; 2019 Jul; 25(7):1045-1053. PubMed ID: 31263283
[TBL] [Abstract][Full Text] [Related]
12. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease.
Lindvall O; Brundin P; Widner H; Rehncrona S; Gustavii B; Frackowiak R; Leenders KL; Sawle G; Rothwell JC; Marsden CD
Science; 1990 Feb; 247(4942):574-7. PubMed ID: 2105529
[TBL] [Abstract][Full Text] [Related]
13. Past, present, and future of cell replacement therapy for parkinson's disease: a novel emphasis on host immune responses.
Park TY; Jeon J; Cha Y; Kim KS
Cell Res; 2024 Jul; 34(7):479-492. PubMed ID: 38777859
[TBL] [Abstract][Full Text] [Related]
14. Cell reprogramming therapy for Parkinson's disease.
Dong W; Liu S; Li S; Wang Z
Neural Regen Res; 2024 Nov; 19(11):2444-2455. PubMed ID: 38526281
[TBL] [Abstract][Full Text] [Related]
15. Cell Replacement Therapy for Brain Repair: Recent Progress and Remaining Challenges for Treating Parkinson's Disease and Cortical Injury.
Harary PM; Jgamadze D; Kim J; Wolf JA; Song H; Ming GL; Cullen DK; Chen HI
Brain Sci; 2023 Nov; 13(12):. PubMed ID: 38137103
[TBL] [Abstract][Full Text] [Related]
16. Unravelling the Parkinson's puzzle, from medications and surgery to stem cells and genes: a comprehensive review of current and future management strategies.
Chandrababu K; Radhakrishnan V; Anjana AS; Rajan R; Sivan U; Krishnan S; Baby Chakrapani PS
Exp Brain Res; 2024 Jan; 242(1):1-23. PubMed ID: 38015243
[TBL] [Abstract][Full Text] [Related]
17. Recipient Reaction and Composition of Autologous Sural Nerve Tissue Grafts into the Human Brain.
Colvett I; Gilmore A; Guzman S; Ledreux A; Quintero JE; Ginjupally DR; Gurwell JA; Slevin JT; Guduru Z; Gerhardt GA; van Horne CG; Granholm AC
J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834764
[TBL] [Abstract][Full Text] [Related]
18. Cell-therapy for Parkinson's disease: a systematic review and meta-analysis.
Wang F; Sun Z; Peng D; Gianchandani S; Le W; Boltze J; Li S
J Transl Med; 2023 Sep; 21(1):601. PubMed ID: 37679754
[TBL] [Abstract][Full Text] [Related]
19. Challenges in the clinical advancement of cell therapies for Parkinson's disease.
Skidmore S; Barker RA
Nat Biomed Eng; 2023 Apr; 7(4):370-386. PubMed ID: 36635420
[TBL] [Abstract][Full Text] [Related]
20. Single-cell transcriptomics reveals the cell fate transitions of human dopaminergic progenitors derived from hESCs.
Liang L; Tian Y; Feng L; Wang C; Feng G; Stacey GN; Shyh-Chang N; Wu J; Hu B; Li W; Hao J; Wang L; Wang Y
Stem Cell Res Ther; 2022 Aug; 13(1):412. PubMed ID: 35964138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
